 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C23H33N3O2 |
| Molar mass | 383.536 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Org 28611 (SCH-900,111) is a drug developed byOrganon International which acts as a potentcannabinoidreceptorfull agonist at both theCB1 andCB2 receptors. It was developed with the aim of finding awater-soluble cannabinoid agonist suitable forintravenous use as ananalgesic,[1] and while it achieved this aim and has progressed as far as Phase IIclinical trials in humans as both asedative and ananalgesic, results against the comparison drugs (midazolam andmorphine respectively) were not particularly favourable in initial testing.[2][3]
 | Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |
